Recent Finacing
Recent Raise
ADC Biotechnology develops and manufactures antibody-drug conjugates using a patented Lock-Release technology to target tumour cells, serving R&D and pharmaceutical clients and expanding into Deeside clinical/commercial manufacturing.
Focus Areas
Recent Investors
Funding round
Investors
